|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.320 USD | +0.87% |
|
+4.50% | +28.89% |
| 05-13 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| 05-13 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Quotes 5-day view: Protalix BioTherapeutics, Inc.
Delayed Quote NYSE
| 2026-06-26 | 2026-06-29 | 2026-06-30 | 2026-07-01 | 2026-07-02 | |
|---|---|---|---|---|---|
| Last | US$2.300 | US$2.350 | US$2.330 | US$2.300 | US$2.320 |
| Volume | 2,544,165 | 540,557 | 500,098 | 436,234 | 472,793 |
| Change | +3.60% | +2.17% | -0.85% | -1.29% | +0.87% |
| Opening | US$2.220 | US$2.310 | US$2.360 | US$2.310 | US$2.300 |
| High | US$2.350 | US$2.380 | US$2.360 | US$2.335 | US$2.355 |
| Low | US$2.215 | US$2.255 | US$2.310 | US$2.260 | US$2.270 |
Performance
| 1 day | +0.87% | ||
| 1 week | +4.50% | ||
| Current month | -0.43% | ||
| 1 month | +16.58% | ||
| 3 months | +7.91% | ||
| 6 months | +33.33% | ||
| Current year | +28.89% | ||
| 1 year | +54.67% | ||
| 3 years | +16.00% | ||
| 5 years | +28.89% | ||
| 10 years | -64.47% |
Volumes
marketsDaily volume
472,793
Estimated daily volume
472,793
Avg. Volume 20 sessions
741,971
Daily volume ratio
0.64
Avg. Volume 20 sessions USD
1,721,372.72
Record volume 1
191,289,000
Record volume 2
19,414,390
Record volume 3
12,716,823
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
186,926,209
Net sales (USD)
52,744,000
Number of employees
226
Sales / Employee (USD)
233,381
Free-Float
96.12 %
Free-Float capitalization (USD)
179,677,592
Average Daily Capital Traded
0.92%
Indicators
Moving average 5 days
2.3
Moving average 20 days
2.122
Moving average 50 days
2.082
Moving average 100 days
2.335
Price spread / (MMA5)
-0.86%
Price spread / (MMA20)
-8.53%
Price spread / (MMA50)
-10.25%
Price spread / (MMA100)
+0.63%
STIM
RSI 9 days
65.37
RSI 14 days
62.54
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.87% | +4.50% | +54.67% | +16.00% | 187M | |
| +1.86% | +7.65% | +55.77% | +158.84% | 1,082B | |
| +3.57% | +7.42% | +69.09% | +58.92% | 633B | |
| +3.99% | +7.37% | +36.87% | +93.77% | 461B | |
| -0.35% | +1.85% | +31.30% | +24.86% | 339B | |
| -0.56% | +2.80% | +39.13% | +28.20% | 301B | |
| -0.08% | +1.52% | +29.96% | +42.13% | 292B | |
| -1.54% | +3.56% | -25.96% | -40.53% | 225B | |
| +3.55% | +6.05% | +26.04% | +68.52% | 202B | |
| +4.21% | +6.00% | +17.72% | +70.33% | 163B | |
| Average | +1.06% | +4.70% | +33.46% | +52.10% | 369.99B | |
| Weighted average by Cap. | +1.04% | +5.54% | +41.79% | +80.52% |
Historical Quotes: Protalix BioTherapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
040fe7325e5f183a252.UlheQ-VHytqqtOYl5sZiazKTeUPukEN32_7DzJFqLiQ.P2w1EqQ9jorGwb9vqKMoJnzwTge85Ak76c2OhOckZkorCwt2syKStMPXtw
| Date | Price | Volume | Total |
|---|---|---|---|
| 16:00:00 | 2.320 | 21,617 | 377,377 |
| 15:59:58 | 2.315 | 206 | 355,760 |
| 15:59:55 | 2.320 | 100 | 355,554 |
| 15:59:55 | 2.315 | 114 | 355,454 |
| 15:59:55 | 2.315 | 120 | 355,340 |
| 15:59:55 | 2.315 | 184 | 355,220 |
| 15:59:53 | 2.315 | 130 | 355,036 |
| 15:59:53 | 2.315 | 300 | 354,906 |
| 15:59:50 | 2.320 | 100 | 354,606 |
| 15:59:50 | 2.320 | 600 | 354,506 |
Course Extremes
| 1 week | 2.26 |  | 2.38 |
| 1 month | 1.94 | | 2.38 |
| Current year | 1.72 | | 3.19 |
| 1 year | 1.36 | | 3.19 |
| 3 years | 0.82 | | 3.19 |
| 5 years | 0.7 | | 3.55 |
| 10 years | 0.7 | | 15.15 |
Monthly variations
Annual variations
| 2026 | +28.89% | ||
| 2025 | -4.26% | ||
| 2024 | +5.62% | ||
| 2023 | +29.93% | ||
| 2022 | +64.72% | ||
| 2021 | -77.09% | ||
| 2020 | +10.67% | ||
| 2019 | +5.47% | ||
| 2018 | -52.96% | ||
| 2017 | +48.58% | ||
| 2016 | -56.37% | ||
| 2015 | -44.57% | ||
| 2014 | -52.70% | ||
| 2013 | -25.05% | ||
| 2012 | +5.27% | ||
| 2011 | -50.60% | ||
| 2010 | +50.76% | ||
| 2009 | +259.78% | ||
| 2008 | -45.88% | ||
| 2007 | -87.48% |
- Stock Market
- Stocks
- PLX Stock
- Quotes Protalix BioTherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
